Company / Gross Margin
Collegium Pharmaceutical, Inc. Gross Margin History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Margin
59.4%
FY2025
5-year range
45.1% / 59.8%
FY2021-FY2025
Trend
-0.7%
vs FY2024
Sector context
#14 of 28
Health Care
What the data says
At 59.4%, Collegium Pharmaceutical, Inc.'s gross margin ranks #14 of 28 in the Health Care sector. Gross Margin has fluctuated over the past 8 years, ranging from 34.7% in FY2019 to 59.8% in FY2024.
Based on SEC 10-K filings.
59.4% in FY2025 with a 5-year CAGR of +1.3%.
Improved from 57.6% to 59.4% over the past 2 years.
Health Care sector context is included.
Gross Margin over time
Growth rates
- 3-Year Change
- +14.2pp
- 5-Year Change
- +1.3pp
- 10-Year Change
- -
Sector benchmark
#14 of 28 in Health CareTop 50% of 28This company 59.4% Sector average 60.3%
▼
-1.6% below sector average
Key checks
Key Insights
- In FY2025, gross margin decreased 0.7% year-over-year.
- Currently 0.9pp below the Health Care sector average.
- Peak gross margin was recorded in FY2024.
- Lowest gross margin in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score 0.96 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 59.4% | -0.7% |
| FY2024 | 59.8% | +3.8% |
| FY2023 | 57.6% | +27.5% |
| FY2022 | 45.1% | -17.0% |
| FY2021 | 54.4% | -6.2% |
| FY2020 | 58.0% | +67.0% |
| FY2019 | 34.7% | -15.1% |
| FY2018 | 40.9% | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026